Hiroki Sano

Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism

Charles E. Grimshaw, Andy Jennings, Ruhi Kamran et al. · PLoS ONE · 2016 · 58 citations · Full text

Medicinal Chemistry, Diabetes Management, Biochemistry +15

SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial

Nobuya Inagaki, Hitoshi Onouchi, Hiroki Sano et al. · The Lancet Diabetes & Endocrinology · 2013 · 54 citations

Diabetes Management, Diabetes, Pharmacology +6

Femtoliter nanofluidic valve utilizing glass deformation

Yutaka Kazoe, Yuriy Pihosh, Hitomi Takahashi et al. · Lab on a Chip · 2019 · 44 citations

Femtoliter Nanofluidic Valve, Engineering, Nanodevices +21

Effects of epidural morphine on gastrointestinal transit in unmedicated horses

Hiroki Sano, Manuel Martin‐Flores, Luiz Santos et al. · Veterinary Anaesthesia and Analgesia · 2011 · 38 citations

Animal Physiology, Equine-assisted Therapy, Animal Science +9

Evaluation of pulse pressure variation and pleth variability index to predict fluid responsiveness in mechanically ventilated isoflurane‐anesthetized dogs

Hiroki Sano, Joonbum Seo, Paul Wightman et al. · Journal of Veterinary Emergency and Critical Care · 2018 · 36 citations